Hankyel Park

Array ( [id] => 1400611 [patent_doc_number] => 06534312 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Vaccines comprising synthetic genes' [patent_app_type] => B1 [patent_app_number] => 09/340798 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23789 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534312.pdf [firstpage_image] =>[orig_patent_app_number] => 09340798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1520559 [patent_doc_number] => 06413771 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof' [patent_app_type] => B1 [patent_app_number] => 09/335697 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 24772 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413771.pdf [firstpage_image] =>[orig_patent_app_number] => 09335697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324967 [patent_doc_number] => 06319666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection' [patent_app_type] => 1 [patent_app_number] => 9/284651 [patent_app_country] => US [patent_app_date] => 1999-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5981 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319666.pdf [firstpage_image] =>[orig_patent_app_number] => 284651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1396748 [patent_doc_number] => 06537776 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Synthetic ligation reassembly in directed evolution' [patent_app_type] => B1 [patent_app_number] => 09/332835 [patent_app_country] => US [patent_app_date] => 1999-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 51375 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537776.pdf [firstpage_image] =>[orig_patent_app_number] => 09332835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292539 [patent_doc_number] => 06183993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Complement-resistant non-mammalian DNA viruses and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/329368 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 40 [patent_no_of_words] => 31040 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183993.pdf [firstpage_image] =>[orig_patent_app_number] => 329368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4422032 [patent_doc_number] => 06177549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/329916 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 29 [patent_no_of_words] => 24952 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177549.pdf [firstpage_image] =>[orig_patent_app_number] => 329916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180965 [patent_doc_number] => 06150138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Expression of a foamy virus envelope protein' [patent_app_type] => 1 [patent_app_number] => 9/305086 [patent_app_country] => US [patent_app_date] => 1999-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6947 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150138.pdf [firstpage_image] =>[orig_patent_app_number] => 305086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292790 [patent_doc_number] => 06197583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Therapeutic compounds' [patent_app_type] => 1 [patent_app_number] => 9/285070 [patent_app_country] => US [patent_app_date] => 1999-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 30 [patent_no_of_words] => 16947 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197583.pdf [firstpage_image] =>[orig_patent_app_number] => 285070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4342983 [patent_doc_number] => 06284536 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Modified immunoglobin molecules and methods for use thereof' [patent_app_type] => 1 [patent_app_number] => 9/295283 [patent_app_country] => US [patent_app_date] => 1999-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 15017 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284536.pdf [firstpage_image] =>[orig_patent_app_number] => 295283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328692 [patent_doc_number] => 06329498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide' [patent_app_type] => 1 [patent_app_number] => 9/284241 [patent_app_country] => US [patent_app_date] => 1999-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8892 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329498.pdf [firstpage_image] =>[orig_patent_app_number] => 284241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407364 [patent_doc_number] => 06265196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Methods for inactivating target DNA and for detecting conformational change in a nucleic acid' [patent_app_type] => 1 [patent_app_number] => 9/281792 [patent_app_country] => US [patent_app_date] => 1999-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13815 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265196.pdf [firstpage_image] =>[orig_patent_app_number] => 281792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1162565 [patent_doc_number] => 06759238 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Multidrug resistance associated proteins and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/281646 [patent_app_country] => US [patent_app_date] => 1999-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 43 [patent_no_of_words] => 27387 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759238.pdf [firstpage_image] =>[orig_patent_app_number] => 09281646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367553 [patent_doc_number] => 06287843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Maize histone deacetylases and their use' [patent_app_type] => 1 [patent_app_number] => 9/282305 [patent_app_country] => US [patent_app_date] => 1999-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25691 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287843.pdf [firstpage_image] =>[orig_patent_app_number] => 282305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4343213 [patent_doc_number] => 06214375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Phospholipid formulations' [patent_app_type] => 1 [patent_app_number] => 9/277600 [patent_app_country] => US [patent_app_date] => 1999-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3765 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214375.pdf [firstpage_image] =>[orig_patent_app_number] => 277600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523492 [patent_doc_number] => 06352842 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Exonucease-mediated gene assembly in directed evolution' [patent_app_type] => B1 [patent_app_number] => 09/276860 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 42556 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352842.pdf [firstpage_image] =>[orig_patent_app_number] => 09276860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349495 [patent_doc_number] => 06291239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 9/276296 [patent_app_country] => US [patent_app_date] => 1999-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 6305 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291239.pdf [firstpage_image] =>[orig_patent_app_number] => 276296 [rel_patent_id] =>[rel_patent_doc_number] =>)